gastrointestinal disease

Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.

Researchers developed a new pill with promising applications for treating pain due to gastrointestinal disorders.

Spatial biology platforms shed light on the cellular and molecular players underlying ulcerative colitis and Crohn’s disease.

Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.

By engineering a probiotic with tiny antibodies from alpacas, scientists created a potential new oral tool to treat deadly diarrheal infections.

New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients

Progenity presents results on PIL Dx capsule in small intestinal bacterial overgrowth

Researchers have discovered that mast cell reactions are behind irritable bowel syndrome

Tiziana and Parexel will conduct Phase 1b/2 study of take-home capsules of Foralumab, an anti-CD3 monoclonal antibody

Promising Phase 3 test results give hope for those with the gastrointestinal disorder